Literature DB >> 17849471

Serum and forskolin cooperate to promote G1 progression in Schwann cells by differentially regulating cyclin D1, cyclin E1, and p27Kip expression.

Jared Iacovelli1, Jorge Lopera, Marga Bott, Elizabeth Baldwin, Annette Khaled, Nizam Uddin, Cristina Fernandez-Valle.   

Abstract

Proliferation of Schwann cells in vitro, unlike most mammalian cells, is not induced by serum alone but additionally requires cAMP elevation and mitogenic stimulation. How these agents cooperate to promote progression through the G1 phase of the cell cycle is unclear. We studied the integrative effects of these compounds on receptor-mediated signaling pathways and regulators of G1 progression. We show that serum alone induces strong cyclical expression of cyclin D1 and E1, 6 and 12 h after addition, respectively. Serum also promotes strong but transient erbB2, ERK, and Akt phosphorylation, but Schwann cells remain arrested in G1 due to high levels of the inhibitor, p27(Kip). Forskolin with serum promotes G1 progression in 22% of Schwann cells between 18 and 24 h by inducing a steady decline in p27(Kip) levels that reaches a nadir at 12 h coinciding with peak cyclin E1 expression. Forskolin also delays neuregulin-induced loss of erbB2 receptors allowing strong acute activation of PI3K, sustained erbB2 phosphorylation and G1 progression in 31% of Schwann cells. We find that the ability of forskolin to decrease p27(Kip) is associated with its ability to decrease Krox-20 expression that is induced by serum and further increased by neuregulin. Our results explain why serum is required but insufficient to stimulate proliferation and identify two routes by which forskolin promotes proliferation in the presence of serum and neuregulin. These findings provide insights into how G1 progression and, cell cycle arrest leading to myelination are regulated in Schwann cells. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17849471     DOI: 10.1002/glia.20578

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  11 in total

1.  SSeCKS is a suppressor in Schwann cell differentiation and myelination.

Authors:  Yuhong Ji; Tao Tao; Chun Cheng; Huiguang Yang; Youhua Wang; Junling Yang; Haiou Liu; Xinxing He; Huiming Wang; Aiguo Shen
Journal:  Neurochem Res       Date:  2009-09-16       Impact factor: 3.996

2.  GABA-B1 Receptor-Null Schwann Cells Exhibit Compromised In Vitro Myelination.

Authors:  Alessandro Faroni; Simona Melfi; Luca Franco Castelnovo; Veronica Bonalume; Deborah Colleoni; Paolo Magni; Marcos J Araúzo-Bravo; Rolland Reinbold; Valerio Magnaghi
Journal:  Mol Neurobiol       Date:  2018-06-12       Impact factor: 5.590

3.  Up-regulation of NF45 correlates with Schwann cell proliferation after sciatic nerve crush.

Authors:  Youhua Wang; Shiran Zhou; Hua Xu; Shixian Yan; Dawei Xu; Yi Zhang
Journal:  J Mol Neurosci       Date:  2015-01-08       Impact factor: 3.444

Review 4.  Negative regulators of schwann cell differentiation-novel targets for peripheral nerve therapies?

Authors:  André Heinen; Helmar C Lehmann; Patrick Küry
Journal:  J Clin Immunol       Date:  2012-09-06       Impact factor: 8.317

5.  Reduced Expression of Glutathione S-Transferase α 4 Promotes Vascular Neointimal Hyperplasia in CKD.

Authors:  Jinlong Luo; Guang Chen; Ming Liang; Aini Xie; Qingtian Li; Qunying Guo; Rajendra Sharma; Jizhong Cheng
Journal:  J Am Soc Nephrol       Date:  2017-11-10       Impact factor: 10.121

6.  Trichomide A, a natural cyclodepsipeptide, exerts immunosuppressive activity against activated T lymphocytes by upregulating SHP2 activation to overcome contact dermatitis.

Authors:  Xingqi Wang; Aihua Zhang; Jian Gao; Wei Chen; Shiyu Wang; Xuefeng Wu; Yan Shen; Yuehai Ke; Zichun Hua; Renxiang Tan; Yang Sun; Qiang Xu
Journal:  J Invest Dermatol       Date:  2014-06-16       Impact factor: 8.551

7.  Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis.

Authors:  Alejandra Petrilli; Marga Bott; Cristina Fernández-Valle
Journal:  Oncotarget       Date:  2013-12

8.  Analysis of Signal Transduction Pathways Downstream M2 Receptor Activation: Effects on Schwann Cell Migration and Morphology.

Authors:  Elisabetta Botticelli; Michael Sebastian Salazar Intriago; Roberta Piovesana; Ada Maria Tata
Journal:  Life (Basel)       Date:  2022-01-29

9.  The QKI-6 and QKI-7 RNA binding proteins block proliferation and promote Schwann cell myelination.

Authors:  Daniel Larocque; Gabriela Fragoso; Jinghan Huang; Walter E Mushynski; Martin Loignon; Stéphane Richard; Guillermina Almazan
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

10.  LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.

Authors:  A Petrilli; A Copik; M Posadas; L-S Chang; D B Welling; M Giovannini; C Fernández-Valle
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.